Develops platform-based digital therapeutics (DTx) and remote patient monitoring (RPM) solutions tailored for dermatology and allergology, combining clinical validation, machine learning, and real-world data integration. These CE-approved medical devices improve patient engagement and treatment adherence by providing personalized support, real-time monitoring, and actionable insights for healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with dermatological and allergological conditions often lack continuous, personalized support and monitoring, leading to suboptimal treatment adherence and difficulty in identifying triggers for disease exacerbations. Traditional methods of patient monitoring rely on infrequent in-person visits, limiting the ability to make timely adjustments to treatment plans based on real-world data.
Solution
Nia Health develops digital therapeutics (DTx) and remote patient monitoring (RPM) solutions designed to improve patient engagement and treatment outcomes in dermatology and allergology. Their platform combines clinical validation, machine learning, and real-world data integration to provide personalized support and real-time monitoring. Patients use mobile apps to track symptoms, document medication usage, and monitor environmental factors, while AI algorithms analyze the data to identify patterns and predict potential flare-ups. Healthcare providers gain access to patient-generated data and AI-driven insights through a web dashboard, enabling them to make informed treatment decisions and provide timely interventions.
Target Audience
The primary target audience includes patients with chronic skin conditions such as eczema, psoriasis, and acne, as well as dermatologists, allergists, and clinical researchers seeking to improve patient outcomes and streamline clinical trials.
Features
- Mobile apps for patients with eczema, psoriasis, and acne to track symptoms, medications, and environmental factors
- AI-powered analytics to identify individual triggers and predict disease exacerbations
- Remote patient monitoring (RPM) system that continuously records and evaluates patient data, alerting physicians to threshold exceedances
- Digital Trial Companion to support clinical trials with state-of-the-art data collection and increased participant compliance
- Integration of real-world evidence (RWE) to provide insights into disease correlations and symptom patterns
- ISO 27001 certified systems ensuring high data protection and security standards
- CE-approved medical devices